Skip to main content

Table 7 Univariate and multivariable Cox proportional hazards model for PFS in stage I-II melanoma patients

From: Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas

Characteristic

Univariate analysis

Multivariable analysis

HR (95% CI)

p

HR (95% CI)

p

Age

 ≤ 55 vs. >55

0.612 (0.357–1.049)

0.074

0.770 (0.451–1.315)

0.338

Sex

 Female vs. Male

0.823 (0.490–1.382)

0.462

0.542 (0.298–0.988)

0.045*

Location

 Mucosa vs. Skin

2.636 (1.223–5.680)

0.013*

2.667 (1.090–6.526)

0.032*

 Acral vs. Skin

2.064 (0.823–5.173)

0.122

2.113 (0.767–5.824)

0.148

 Other vs. Skin

1.186 (0.395–3.558)

0.761

1.069 (0.321–3.560)

0.913

Neuroendocrinea

0.854 (0.510–1.432)

0.550

0.865 (0.477–1.569)

0.633

BRAF alternations

0.797 (0.452–1.406)

0.434

1.071 (0.546–2.101)

0.842

  1. a CgA, Syn or CD56
  2. * p < 0.05